5 Oversold Healthcare Stocks To Buy Right Now

Page 5 of 5

1. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Number of Hedge Fund Holders: 33

14-day RSI as of March 12: 27.45

Citigroup analysts maintain a Buy rating and a $30.19 price target on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) as of March 12.

There were 33 hedge funds long ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) in the fourth quarter, with a total stake value of $1.9 billion.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a biotechnology company based in San Diego, California. The company develops and commercializes innovative medicines addressing unmet medical needs in central nervous system disorders and rare diseases in the US.

Follow Acadia Pharmaceuticals Inc (NASDAQ:ACAD)

See also 15 States with the Best Healthcare in the US and 20 Cheapest Places to Retire with Good Healthcare.

Page 5 of 5